QR-kod

MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature

Tuberculosis (TB) is accountable for considerable global morbidity and mortality. Effective TB therapy with multiple drugs completes in about six months. The longer duration of TB therapy challenges patient compliance and contributes to treatment collapse and drug resistance (DR) progress. Therefore...

Full beskrivning

Sparad:
Huvudupphov: Mohd. Imran, Mandeep Kumar Arora, Anurag Chaudhary, Shah Alam Khan, Mehnaz Kamal, Manal Mutlaq Alshammari, Raghad Mohammad Alharbi, Nuha Abdullah Althomali, Ibrahim Mohammed Alzimam, Abdullah Ayed Alshammari, Bashair Hamed Alharbi, Amer Alshengeti, Abdulmonem A. Alsaleh, Shayea A. Alqahtani, Ali A. Rabaan
Materialtyp: Artigo
Språk:Inglês
Utgiven: MDPI AG 2022-11-01
Serie:Biomedicines
Ämnen:
tuberculosis
drug-resistance
Mmpl3
SQ109
clinical studies
patent
Länkar:https://www.mdpi.com/2227-9059/10/11/2793
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk